Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

ABSTRACT:

Purpose

To compare baseline characteristics, visual acuity (VA), and morphologic outcomes between eyes with retinal angiomatous proliferation (RAP) and all other eyes among patients with neovascular age-related macular degeneration (NVAMD) treated with anti-vascular endothelial growth factor (VEGF) drugs.

Design

Prospective cohort study within the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

Participants

Patients with NVAMD.

Methods

Reading center staff evaluated digital color fundus photographs, fluorescein angiography (FA) images, and optical coherence tomography (OCT) scans of eyes with NVAMD treated with either ranibizumab or bevacizumab over a 2-year period. Retinal angiomatous proliferation was identified by the intense intra-r

SUBMITTER: Daniel E 

PROVIDER: S-EPMC4766028 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature